2020 Komen CSNJ Breast Cancer Conference

Rutgers University-Camden Campus Center
326 Penn Street, Camden, NJ 08102



See 2019 Photos & More



This year’s conference focuses on bringing together oncology experts to share their knowledge and approaches to advancing precision medicine in clinical practice – as it is rapidly becoming the most studied form of cancer therapy and the standard of care for patients with advanced breast cancer. The goal is to educate the care team on emerging developments and advancements of diagnostic, prognostic and therapeutic approaches that are advancing precision medicine in breast cancer care.

The conference agenda will feature a keynote presentation, lunch presentation, six breakout sessions and networking opportunities.

Jointly Provided by Susan G. Komen Central and South Jersey and American Academy of CME, Inc.


8 am – 8:30 am — Registration & Breakfast
8:30 am — Keynote Presentation by Komen Scholar, Dr. Antonio Wolff
9:45 am – 10:45 am — First Round of Breakouts featuring Dr. Shridar Ganesan & Dr. Karen Correa
10:45 am — Snack Break
11 am – 12 pm — Second Round of Breakouts
12 pm — Lunch & Presentation by Dr. Patrick Borgen


Meet Our Keynote Speaker

Komen Scholar Since 2010
Johns Hopkins University School of Medicine
Baltimore, MD

Antonio C. Wolff, M.D., is Professor of Oncology at Johns Hopkins University and a member of the Johns Hopkins Kimmel Cancer Center. A clinician and researcher, Dr. Wolff’s research interests include new treatment strategies, the development and implementation of prognostic and predictive biomarkers (tissue, blood, and imaging) in clinical practice, and how to improve the survivorship experience of breast cancer patients and their caregivers.

He promotes the implementation of research findings in clinical practice, survivorship, and quality of care for breast cancer patients. Dr. Wolff is the Chief Operating Officer of the Translational Breast Cancer Research Consortium (TBCRC)—a research group funded by Komen and that convenes a multidisciplinary group of researchers who plan and conduct studies to better understand breast cancer biology and test new therapies. He is also an Associate Editor of the Journal of Clinical Oncology and Chair of the NCI ECOG-ACRIN Breast Cancer Committee. Dr. Wolff’s Komen funding supports the development of a tissue and bodily fluid repository that has patient samples linked to clinical data and surveys that can be used to answer critical research questions.

2020 Sponsors

< >
Go to Top